Skip to main content
TipRanks
Go Ultimate75% OFF

CANbridge Pharmaceuticals Inc. (1228) Income Statement

0 Followers

CANbridge Pharmaceuticals Inc. Income Statement

Last quarter (Q2 2026), CANbridge Pharmaceuticals Inc.'s total revenue was ¥13.97M, an increase of 25.58% from the same quarter last year. In Q2, CANbridge Pharmaceuticals Inc.'s net income was ¥-18.55M. See CANbridge Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 49.98M¥ 85.10M¥ 102.87M¥ 78.97M¥ 31.16M
¥ 36.55M¥ 54.30M¥ 64.16M¥ 48.89M¥ 18.78M
¥ 129.25M¥ 394.82M¥ 429.28M¥ 506.86M¥ 673.52M
Depreciation and Amortization¥ 12.15M¥ 27.25M¥ 28.46M¥ 21.98M¥ 15.71M
¥ -80.55M¥ -313.26M¥ -341.43M¥ -454.63M¥ -1.06B
¥ -92.70M¥ -340.51M¥ -366.55M¥ -457.97M¥ -655.15M
¥ 107.52M¥ -102.10M¥ -12.29M¥ -25.51M¥ -421.86M
¥ 14.82M¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B
¥ 14.82M¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B
Per Share Metrics
Basic EPS¥ 0.03¥ -1.04¥ -0.89¥ -1.14¥ -11.43
Diluted EPS¥ 0.03¥ -1.04¥ -0.89¥ -1.14¥ -11.43
Weighted Average Shares Outstanding456.90M424.83M424.38M424.21M94.24M
Weighted Average Shares Outstanding (Diluted)456.90M424.83M424.38M424.21M94.24M

Currency in CNY

CANbridge Pharmaceuticals Inc. Earnings and Revenue History

-1.2B-600M0600M-16000 %-8000 %0 %8000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin